Transcription factor networks derived from breast cancer stem cells control the immune response in the basal subtype

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Da Silveira, W A ^a,b   Palma, P V B ^c   Sicchieri, R D ^a   Villacis, R A R ^f   Mandarano, L R M ^a   Oliveira, T M G ^a   Antonio, H M R ^a   Andrade, J M ^a   Muglia, V F ^a   Rogatto, S R ^d,e,g   Theillet, C ^b,h   Du Manoir, S ^b   Tiezzi, D G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^c National Institute of Science and Technology in Stem Cell and Cell Therapy   (Brazil)

^d LILLEBAELT HOSPITAL   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f UNIVERSITY OF BRASILIA   (Brazil)

^g SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^h CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN BINDING; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ANIMAL; BREAST TUMOR; CANCER STEM CELL; DISEASE MODEL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; XENOGRAFT;

ANIMALS; BIOMARKERS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; MICE; NEOPLASTIC STEM CELLS; PHENOTYPE; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 85020379691     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02761-6     Document Type: Article

References (58)

1. Torre, L. A., et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87-108, doi: 10.3322/caac.21262 (2015
2. Hanahan, D., & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674, doi: 10.1016/j.cell.2011.02.013 (2011
3. Sorlie, T., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100, 8418-8423, doi: 10.1073/pnas.0932692100 (2003
4. Guedj, M., et al. A refined molecular taxonomy of breast cancer. Oncogene 31, 1196-1206 (2012
5. Luo, M., et al. Breast cancer stem cells: current advances and clinical implications. Methods Mol Biol 1293, 1-49, doi: 10.1007/978-1-4939-2519-3-1 (2015
6. Tiezzi, D. G., et al. CD44+/CD24-cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast. Med Oncol 29, 1479-1485, doi: 10.1007/s12032-011-0014-x (2012
7. Shipitsin, M., & Polyak, K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 88, 459-463, doi: 10.1038/labinvest.2008.14 (2008
8. Chaffer, C. L., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences 108, 7950-7955 (2011
9. Chaffer, C. L., et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74 (2013
10. Schmitt, F., Ricardo, S., Vieira, A. F., Dionisio, M. R., & Paredes, J. Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Virchows Arch 460, 545-553, doi: 10.1007/s00428-012-1237-8 (2012
11. Charafe-Jauffret, E., et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res 73, 7290-7300, doi: 10.1158/0008-5472.CAN-12-4704 (2013
12. Zhou, W., et al. ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma. Leukemia 28, 1155-1158, doi: 10.1038/leu.2013.383 (2014
13. Kim, M. P., et al. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One 6, e20636, doi: 10.1371/journal.pone.0020636 (2011
14. Rasper, M., et al. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol 12, 1024-1033, doi: 10.1093/neuonc/noq070 (2010
15. Carro, M. S., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325, doi: 10.1038/nature08712 (2010
16. Vaquerizas, J. M., Kummerfeld, S. K., Teichmann, S. A., & Luscombe, N. M. A census of human transcription factors: function, expression and evolution. Nat Rev Genet 10, 252-263, doi: 10.1038/nrg2538 (2009
17. Alon, U. An introduction to systems biology: design principles of biological circuits. (CRC press, 2006
18. De Craene, B., & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13, 97-110, doi: 10.1038/nrc3447 (2013
19. Miyake, T., et al. GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci 103, 913-920, doi: 10.1111/j.1349-7006.2012.02231.x (2012
20. Margolin, A. A., et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7(Suppl 1), S7, doi: 10.1186/1471-2105-7-s1-s7 (2006
21. Györffy, B., et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123, 725-731, doi: 10.1007/s10549-009-0674-9 Date of Acess: 28/01/2017 (2010
22. Schnitt, S. J. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol. 23(Suppl 2), S60-64, doi: 10.1038/modpathol.2010.33 (2010
23. Teschendorff, A. E., et al. Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. BMC Cancer 10, 604, doi: 10.1186/1471-2407-10-604 (2010
24. Sato, R., Semba, T., Saya, H., & Arima, Y. Stem Cells and Epithelial Mesenchymal Transition (EMT) in Cancer: Biological Implications and Therapeutic Targets. STEM CELLS (2016
25. Ocaña, O. H., et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer cell 22, 709-724 (2012
26. Soundararajan, R., Paranjape, A. N., Barsan, V., Chang, J. T., & Mani, S. A. A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome. Scientific reports 5 (2015
27. John, L. B., & Ward, A. C. The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48, 1272-1278, doi: 10.1016/j.molimm.2011.03.006 (2011
28. Rebollo, A., & Schmitt, C. Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol 81, 171-175, doi: 10.1046/j.1440-1711.2003.01159.x (2003
29. Bernardi, R., Papa, A., & Pandolfi, P. P. Regulation of apoptosis by PML and the PML-NBs. Oncogene 27, 6299-6312, doi: 10.1038/onc.2008.305 (2008
30. Granito, A., et al. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol 105, 125-131, doi: 10.1038/ajg.2009.596 (2010
31. Bourdeau, V., Baudry, D., & Ferbeyre, G. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Front Biosci (Landmark Ed) 14, 475-485 (2009
32. Zhang, S., et al. Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer. Sci Rep 5, 16066, doi: 10.1038/srep16066 (2015
33. Pasini, D., Bracken, A. P., & Helin, K. Polycomb group proteins in cell cycle progression and cancer. Cell Cycle 3, 396-400 (2004
34. Schuettengruber, B., & Cavalli, G. Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development 136, 3531-3542, doi: 10.1242/dev.033902 (2009
35. Brass, A. L., et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926, doi: 10.1126/science.1152725 (2008
36. Lamkanfi, M., & Kanneganti, T. D. Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol 42, 21-24, doi: 10.1016/j.biocel.2009.09.013 (2010
37. Sharma, N., Akhade, A. S., & Qadri, A. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells. Innate Immun 22, 238-244, doi: 10.1177/1753425916632305 (2016
38. Ackermann, J. A., et al. Syk tyrosine kinase is critical for B cell antibody responses and memory B cell survival. J Immunol 194, 4650-4656, doi: 10.4049/jimmunol.1500461 (2015
39. Ozaki, N., et al. Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anticollagen antibody-induced arthritis. Int Immunol 24, 539-550, doi: 10.1093/intimm/dxs078 (2012
40. Xia, T. S., et al. Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells. Med Oncol 29, 448-453, doi: 10.1007/s12032-011-9865-4 (2012
41. Gajewski, T. F., Schreiber, H., & Fu, Y. X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14, 1014-1022, doi: 10.1038/ni.2703 (2013
42. du Manoir, S., et al. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse. Mol Oncol 8, 431-443, doi: 10.1016/j.molonc.2013.11.010 (2014
43. Williams, S. A., Anderson, W. C., Santaguida, M. T., & Dylla, S. J. Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Lab Invest 93, 970-982, doi: 10.1038/labinvest.2013.92 (2013
44. DeRose, Y. S., et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17, 1514-1520, doi: 10.1038/nm.2454 (2011
45. Waldhauer, I., & Steinle, A. NK cells and cancer immunosurveillance. Oncogene 27, 5932-5943, doi: 10.1038/onc.2008.267 (2008
46. Strieter, R. M., Belperio, J. A., Phillips, R. J., & Keane, M. P. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14, 195-200, doi: 10.1016/j.semcancer.2003.10.006 (2004
47. Robertson, M. J. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71, 173-183 (2002
48. Meyer, M., et al. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection. Eur J Immunol 31, 2521-2527, doi: 10.1002/1521-4141(200108)31: 8& #60; 2521: AID-IMMU2521& #62; 3.0.CO; 2-Q (2001
49. Teruya-Feldstein, J., et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 90, 4099-4105 (1997
50. Lavergne, E., et al. Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Immunol 173, 3755-3762 (2004
51. Suzuki, K., et al. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer. J Leukoc Biol 69, 531-537 (2001
52. Matsuo, Y., et al. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 124, 853-861, doi: 10.1002/ijc.24040 (2009
53. Charafe-Jauffret, E., et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69, 1302-1313, doi: 10.1158/0008-5472.CAN-08-2741 (2009
54. Terry, S., & Chouaib, S. EMT in immuno-resistance. Oncoscience 2, 841 (2015
55. Alsuliman, A., et al. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells. Molecular cancer 14, 1 (2015
56. Liu, S., et al. Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts. Stem Cell Reports 2, 78-91, doi: 10.1016/j.stemcr.2013.11.009 (2014
57. Subramanian, A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545-15550, doi: 10.1073/pnas.0506580102 Date of Acess: 20/03/2017 (2005
58. Kong, Y. M., et al. Toward an ontology-based framework for clinical research databases. J Biomed Inform 44, 48-58, doi: 10.1016/j. jbi.2010.05.001 (2011